Atai Life Sciences Total Liabilities 2020-2025 | ATAI

Atai Life Sciences total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2024 $43
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $44
2024-12-31 $43
2024-09-30 $51
2024-06-30 $47
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.467B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.070B 19.78
Encompass Health (EHC) United States $12.070B 25.59
DaVita (DVA) United States $10.252B 14.41
Chemed (CHE) United States $7.989B 25.11
Elanco Animal Health (ELAN) United States $6.620B 14.18
Option Care Health (OPCH) United States $5.168B 23.04
RadNet (RDNT) United States $4.286B 272.00
Amedisys (AMED) United States $3.213B 21.61
Addus HomeCare (ADUS) United States $2.119B 23.26
LifeStance Health (LFST) United States $1.917B 0.00
Astrana Health (ASTH) United States $1.360B 33.69
U.S Physical Therapy (USPH) United States $1.121B 28.94
Pennant (PNTG) United States $0.967B 35.52
Aveanna Healthcare Holdings (AVAH) United States $0.935B 53.22
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00